Shandong Kaisheng New Materials (301069)
Search documents
凯盛新材(301069) - 西南证券股份有限公司关于山东凯盛新材料股份有限公司2024年度内部控制评价报告的核查意见
2025-03-14 12:31
西南证券股份有限公司 关于山东凯盛新材料股份有限公司 2024 年度内部控制评价报告的核查意见 西南证券股份有限公司(以下简称"西南证券"或"保荐机构")作为山东凯盛 新材料股份有限公司(以下简称"凯盛新材"或"公司")首次公开发行股票及向不 特定对象发行可转换公司债券的保荐机构,根据《证券发行上市保荐业务管理办 法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监 管指引第 2 号——创业板上市公司规范运作》等有关规定,对凯盛新材 2024 年 度内部控制评价报告进行了核查,核查情况及核查意见如下: 一、内部控制评价的依据、范围、程序和方法 (二)内部控制评价范围 公司按照风险导向原则确定纳入评价范围的业务和事项以及高风险领域。纳 入评价范围的主要单位包括:山东凯盛新材料股份有限公司、潍坊凯盛新材料有 限公司、山东凯斯通化学有限公司和山东产研高性能材料技术研究院有限公司; 纳入评价范围单位资产总额占公司合并财务报表资产总额的 100%,营业收入合 计占公司合并财务报表营业收入总额的 100%。公司在确定内部控制评价范围时, 全面考虑了公司及所有部门、下属单位的所有业务和事项,纳入评价范围的 ...
凯盛新材(301069) - 2024年年度财务报告
2025-03-14 12:31
山东凯盛新材料股份有限公司 2024 年度财务报告 山东凯盛新材料股份有限公司 2024 年度财务报告 2025 年 3 月 15 日 1 山东凯盛新材料股份有限公司 2024 年度财务报告 第十节 财务报告 一、审计报告 | 审计意见类型 | 标准的无保留意见 | | --- | --- | | 审计报告签署日期 | 2025 年 03 月 13 日 | | 审计机构名称 | 四川华信(集团)会计师事务所(特殊普通合伙) | | 注册会计师姓名 | 陈杰、李鲜、唐秀英 | 审计报告正文 审计报告 川华信审(2025)第 0031 号 山东凯盛新材料股份有限公司全体股东: 一、审计意见 我们审计了山东凯盛新材料股份有限公司(以下简称:"凯盛新材")财务报表,包括 2024 年 12 月 31 日的合并及 母公司资产负债表,2024 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公司股东权益变动表以及相 关财务报表附注。 我们认为,后附的财务报表在所有重大方面按照企业会计准则的规定编制,公允反映了凯盛新材 2024 年 12 月 31 日 的合并及母公司财务状况以及 2024 年度的合并及母公司经营 ...
凯盛新材(301069) - 董事会对独董独立性评估的专项意见
2025-03-14 12:31
经核查:公司独立董事朱清滨、邹健、田文利的任职经历以及签署的相关自 查文件,上述人员未在公司担任除独立董事以外的任何职务,也未在公司主要股 东公司担任任何职务,与公司以及主要股东之间不存在利害关系或其他可能妨碍 其进行独立客观判断的关系。 因此,公司独立董事符合《上市公司独立董事管理办法》《深圳证券交易所 创业板股票上市规则》和《深圳证券交易所上市公司自律监管指引第 2 号-创业 板上市公司规范运作》中对独立董事独立性的相关要求。 董事会关于独立董事独立性情况的专项意见 2025 年 3 月 15 日 根据中国证监会《上市公司独立董事管理办法》《深圳证券交易所创业板股 票上市规则》和《深圳证券交易所上市公司自律监管指引第 2 号-创业板上市公 司规范运作》等要求,山东凯盛新材料股份有限公司(以下简称"公司")董事 会,就公司现任独立董事朱清滨、邹健、田文利的独立性情况进行评估并出具如 下专项意见: 山东凯盛新材料股份有限公司 山东凯盛新材料股份有限公司董事会 ...
凯盛新材(301069) - 2024年度监事会工作报告
2025-03-14 12:31
2024 年度监事会工作报告 2024 年度监事会工作报告 山东凯盛新材料股份有限公司(以下简称"公司")监事会在 2024 年度根据 《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和国证券法》 (以下简称"《证券法》")、《深圳证券交易所创业板股票上市规则》《深圳证券交 易所上市公司自律监管指引第 2 号—创业板上市公司规范运作》等法律法规、 部门规章、规范性文件及《公司章程》的有关规定,认真履行监事会的各项职责 和义务,维护公司及股东的合法权益。本年度监事会对公司依法运作情况进行了 检查,特别是对公司的财务状况、股东大会及董事会的召开程序以及公司董事、 高级管理人员履行职责情况等方面实施了有效监督,为公司规范运作、完善和提 升治理水平发挥了积极作用,较好地维护了公司利益和全体股东的合法权益。现 将监事会 2024 年度的主要工作情况报告如下: 一、2024 年度监事会工作情况 (一)监事会会议召开情况 报告期内,公司监事会共召开了 6 次会议,3 名监事均亲自出席会议,无缺 席会议的情况。会议的召集程序、表决方式和决议内容均符合有关法律、法规和 《公司章程》的规定,经监事会审议通过的具体 ...
凯盛新材(301069) - 西南证券股份有限公司关于山东凯盛新材料股份有限公司2024年度募集资金存放与使用情况的核查报告
2025-03-14 12:31
西南证券股份有限公司 关于山东凯盛新材料股份有限公司 2024 年度募集资金存放与使用情况的核查报告 西南证券股份有限公司(以下简称"西南证券"、"保荐机构")作为山东凯 盛新材料股份有限公司(以下简称"凯盛新材"、"公司")首次公开发行股票及 向不特定对象发行可转换公司债券的保荐机构,根据《证券发行上市保荐业务 管理办法》《深圳证券交易所上市公司保荐工作指引》《深圳证券交易所创业 板股票上市规则》《深圳证券交易所上市公司自律监管指引第2号——创业板上 市公司规范运作》及《上市公司监管指引第2号——上市公司募集资金管理和使 用的监管要求》等相关法律、法规和规范性文件的规定,就凯盛新材2024年募 集资金存放与使用情况进行了认真、审慎的核查,核查具体情况如下: 一、 募集资金基本情况 (一)首次公开发行募集资金 1、募集资金到位情况 经中国证券监督管理委员会 2021 年 8 月 10 日下发的《关于同意山东凯盛新 材料股份有限公司首次公开发行股票注册的批复》(证监许可〔2021〕2626 号), 同意公司首次公开发行人民币普通股(A 股)股票 6,000 万股,每股面值 1 元, 每股发行价格为人民币 5.1 ...
凯盛新材(301069) - 关于召开2024年年度股东大会的通知公告
2025-03-14 12:30
| 证券代码:301069 | 证券简称:凯盛新材 公告编号:2025-010 | | --- | --- | | 债券代码:123233 | 债券简称:凯盛转债 | 山东凯盛新材料股份有限公司 关于召开2024年年度股东大会的通知公告 本公司及董事会全体成员保证公告内容真实、准确和完整,并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、召开会议的基本情况 1、股东大会届次:2024 年年度股东大会。 2、股东大会的召集人:公司董事会。 山东凯盛新材料股份有限公司(以下简称"公司")第三届董事会第二十九 次会议于 2025 年 3 月 13 日召开,会议审议通过了《关于召开 2024 年年度股东 大会的议案》。 3、会议召开的合法、合规性: 本次股东大会的召集和召开符合《中华人民共和国公司法》《上市公司股东 大会规则》等法律、法规、规范性文件及《公司章程》《股东大会议事规则》的 有关规定。 1 记在册的公司全体股东均有权出席股东大会,并可以以书面形式委托代理人出席 会议和参加表决,该股东代理人不必是本公司股东(授权委托书见附件二); (2)公司董事、高级管理人员; (3)公司聘请的律师。 4、会议 ...
凯盛新材(301069) - 2024 Q4 - 年度财报
2025-03-14 12:30
Financial Performance - In 2024, the company's revenue decreased by 5.97% to ¥927,932,105.81 compared to ¥986,897,245.84 in 2023[22] - The net profit attributable to shareholders dropped by 64.56% to ¥55,987,316.48 from ¥157,989,001.88 in the previous year[22] - The net profit after deducting non-recurring gains and losses fell by 80.56% to ¥29,515,889.67, down from ¥151,859,536.11 in 2023[22] - The basic earnings per share decreased by 64.56% to ¥0.1331 from ¥0.3756 in the previous year[22] - The total assets at the end of 2024 were ¥2,388,723,256.19, a decrease of 3.79% from ¥2,482,942,697.11 in 2023[22] - The company's total revenue for Q1 2024 was approximately ¥239.94 million, Q2 was ¥254.71 million, Q3 was ¥201.35 million, and Q4 was ¥231.94 million[24] - The net profit attributable to shareholders for Q1 2024 was ¥25.70 million, Q2 was ¥28.31 million, Q3 showed a loss of ¥1.76 million, and Q4 was ¥3.74 million[24] - The net profit after deducting non-recurring gains and losses for Q1 2024 was ¥21.68 million, Q2 was ¥20.41 million, Q3 was a loss of ¥6.23 million, and Q4 was a loss of ¥6.34 million[25] - The net cash flow from operating activities for Q1 2024 was ¥13.73 million, Q2 was a negative ¥1.26 million, Q3 was ¥33.62 million, and Q4 was ¥5.64 million[25] Research and Development - The company plans to enhance R&D innovation and improve operational quality to adapt to the changing international environment[4] - The company has increased its R&D investment and improved production processes, focusing on green circular economy practices[35] - The R&D team consists of 195 personnel, including 10 with doctoral degrees, focusing on high-end chemical products and high-performance polymer materials[42] - The company's R&D investment amounted to ¥53,803,033.87 in 2024, representing 5.80% of its operating revenue, an increase from 5.22% in 2023[75] - The total number of R&D personnel increased to 195 in 2024, a rise of 1.56% compared to 192 in 2023[75] Market and Product Development - The company is a leading producer of chlorosulfonic acid and aramid polymer monomers, with significant market influence and established partnerships with major manufacturers in Japan and South Korea[34] - The company is focused on developing new lithium-ion battery electrolyte products and improving production processes, which are expected to positively impact future operations[72] - The company is actively expanding its product lines, including a 1,000 tons/year chlorinated diphenyl sulfone technical transformation project, which is currently in operation[50] - The company is focusing on expanding its product range through the development of new chemical products, including high-purity chlorinated compounds and sulfonated polyether ketones[74] - The company aims to enhance its market competitiveness by optimizing production processes and reducing costs through advanced research and development initiatives[74] Environmental and Safety Management - The company emphasizes safety and environmental management, adhering to various environmental laws and implementing measures to reduce emissions and enhance waste treatment[43] - The company has established an environmental management department and implemented regulations to ensure compliance with environmental laws[107] - The company has implemented a comprehensive safety risk management system, utilizing HAZOP analysis to identify and assess safety risks across processes and facilities[186] - The company has committed to environmental protection by adhering to national and local environmental laws, ensuring that all pollutants were within discharge standards during the reporting period[182] - The company has established an emergency response plan for environmental incidents, enhancing its ability to manage potential pollution risks[173] Corporate Governance - The company has conducted multiple shareholder meetings to ensure compliance with legal requirements and protect shareholder rights[114] - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with governance standards[116] - The company maintains a high level of information disclosure and transparency, utilizing platforms such as China Securities Journal and CNINFO for communication with investors[119] - The company has established an internal control system to regulate management and mitigate risks, ensuring compliance with relevant laws and regulations[118] - The company has not reported any instances of the controlling shareholder interfering with its decision-making or operations, ensuring independence in business and financial matters[122] Financial Management - The company achieved a total cash inflow from operating activities of ¥680,413,405.55, an increase of 11.47% from ¥610,382,741.55 in 2023[77] - The net cash flow from investment activities decreased by 3,161.94% year-on-year, attributed to increased management of financial assets based on operational funding needs[78] - The net cash flow from financing activities fell by 116.27% year-on-year, mainly due to the previous year's issuance of convertible bonds that raised ¥639,730,000[78] - The company reported a credit impairment loss of CNY -14,282,523.01, which is -23.60% of total profit, mainly due to the provision for bad debts on other receivables by subsidiaries[79] - The company has received government subsidies and deferred income amortization contributing CNY 14,795,057.09, which is 24.45% of total profit[79] Production and Operational Efficiency - The company employs a production model of "sales-driven production + strategic inventory," ensuring timely and quality product delivery while adhering to safety and environmental standards[38] - The company has implemented automated control systems in production to ensure stability and safety, alongside energy-saving and quality-enhancing measures[40] - The company has established long-term stable relationships with major suppliers for essential raw materials, ensuring a reliable supply chain[38] - The company has a strong technical accumulation and process advantages, with core technologies in the production, purification, and testing of chlorosulfonic acid and acyl chloride products, achieving a product purity of over 99%[51] - The company has implemented digital and automated upgrades to enhance production efficiency, resulting in a noticeable decrease in steam consumption[176] Strategic Planning - The company will focus on sustainable development and market share expansion as part of its long-term strategy[4] - The strategic development plan includes extending from fine chemicals to high-performance polymer materials and new energy sectors, enhancing overall competitiveness[56] - The company is actively pursuing potential mergers and acquisitions to enhance its product offerings and market reach[129] - The company plans to reduce its chlorosulfonic acid production capacity by 50,000 tons within three years, ensuring that the revenue from chlorosulfonic acid products accounts for less than 15% of its main business income[193] - The company has committed to a long-term strategy of sustainable and efficient development, focusing on green and circular economy practices[103]
凯盛新材(301069) - 董事会决议公告
2025-03-14 12:30
| 证券代码:301069 | 证券简称:凯盛新材 公告编号:2025-004 | | --- | --- | | 债券代码:123233 | 债券简称:凯盛转债 | 山东凯盛新材料股份有限公司 第三届董事会第二十九次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整,并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、会议召开及议案审议情况 - 1 - (四)会议以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过了《2025 年度预算报告》 山东凯盛新材料股份有限公司(以下简称"公司")第三届董事会第二十九 次会议通知于 2025 年 3 月 3 日以电子邮件的形式发出,2025 年 3 月 13 日于公 司会议室通过"现场+通讯"的方式召开,公司 9 名董事都参加了本次会议,会 议的通知及召开符合《公司法》及《公司章程》的规定,合法有效。本次会议由 董事长王加荣先生主持,经与会各位董事认真讨论研究,审议并通过了以下议案: (一)会议以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过了《2024 年度总经理工作报告》 (二)会议以 9 票赞成、0 票反对、0 票弃权的表决 ...
凯盛新材(301069) - 第三届董事会第二十八次会议决议公告
2025-02-21 08:45
山东凯盛新材料股份有限公司(以下简称"公司")第三届董事会第二十八 次会议通知于 2025 年 2 月 18 日以电子邮件的形式发出,2025 年 2 月 21 日通过 通讯表决的方式召开,公司 9 名董事都参加了本次会议,会议的通知及召开符合 《公司法》及《公司章程》的规定,合法有效。本次会议由公司董事长王加荣先 生主持,经与会各位董事认真讨论研究,以 9 票赞成、0 票反对、0 票弃权的表 决结果审议通过了《关于制定<市值管理制度>的议案》: 为进一步加强公司市值管理工作,维护公司及广大投资者合法权益,公司积 极响应中国证监会《上市公司监管指引第 10 号—市值管理》关于鼓励上市公司 建立市值管理制度的号召,根据《中华人民共和国公司法》《中华人民共和国证 券法》等法律、法规及《深圳证券交易所股票上市规则》及其他相关规定,现决 定制定公司《市值管理制度》。 二、备查文件 第三届董事会第二十八次会议决议。 特此公告。 | 证券代码:301069 | 证券简称:凯盛新材 公告编号:2025-003 | | --- | --- | | 债券代码:123233 | 债券简称:凯盛转债 | 山东凯盛新材料股份有限公司 ...
凯盛新材(301069) - 2024 Q4 - 年度业绩预告
2025-01-17 11:35
Financial Performance Forecast - The company expects a net profit attributable to shareholders of between 47 million and 61 million RMB for 2024, representing a decline of 70.25% to 61.39% compared to the previous year's profit of 157.99 million RMB[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 24 million and 31 million RMB, a decrease of 84.20% to 79.59% from last year's profit of 151.86 million RMB[4] Reasons for Decline - The decline in performance is attributed to decreased demand in the downstream market and intensified industry competition, leading to a drop in both volume and price of main products[6] - The company incurred interest expenses exceeding 30 million RMB from convertible bond fundraising, contributing to the overall decline in revenue and profit[6] Financial Reporting - The performance forecast is based on preliminary calculations by the company's finance department and has not been audited by an accounting firm[7]